Connect Health Solutions in association with Telcare delivers the world's first GSM based Blood Glucose Monitoring Device. We all want to live simpler, healthier lives. If you have been diagnosed with diabetes, Connect Health Solutions is here to help. So you control your condition. It doesn't control you.
For a person living with diabetes, this means immediate feedback after each blood sugar reading, time stamped logging, real time teachable moments and clinical support when required.
Timely clinical guidance is a challenge when doctors lack visibility of day-to-day changes in a patient’s health. Telcare eliminates this obstacle by providing actionable patient insights at the right time in the right form. Notifications and easy-to-read charts and graphs support monitoring beyond the office visit. Doctors are now empowered to provide guidance and encouragement when it’s needed most. Telcare provides multiple channels for you to engage your members. Telcare can be seamlessly integrated into a health plan’s care management strategy, including connecting with third-party population health solutions. The result is members who feel taken care of and not treated like a number. Better compliance and clinical outcomes are the result.
Immediately after each test with the cellular-enabled meter, patients receive personalized, contextual messaging right on the meter’s screen, which helps influence behaviour at the most teachable moment. In response to specific levels of blood sugar readings, triggered messages can be automatically generated. There’s also a custom messaging tool that lets clinicians send individual messages to the meter, a mobile, or email address. For people with diabetes, there are multiple libraries for Type 2, Type 1, and gestational patients, all designed to provide personalized engagement.
Make visits more effective: Clinic visits for patients with chronic conditions are often focused on review of patient logs with little time for meaningful dialogue. Through simple integration with your practice management workflow, Telcare makes it straightforward to monitor your chronically ill patients. Time-stamped readings allow you to monitor patients beyond the office. With timely insights and two-way messaging, office visits can be focused on more important opportunities for proactive care.
Telcare is the first cellular-enabled solution that connects everyone who can help you manage your condition: healthcare professionals, clinical services, educational resources, and your network of family and friends. We send you messages and reminders, along with personalized education, and we keep your doctor in the loop with timely updates on your health. You can also allow family and friends who are caregivers access to critical health data. The goal is simple: to make managing your health a routine, not an obstacle.
When you have a chronic condition, you’re certainly not alone. A lot of people care about you.
Have easy and timely access to critical patient data that helps them partner with you to more effectively manage your health
Your family get peace of mind, knowing that you and your clinical team are actively managing your condition.
Your friends get peace-of-mind, knowing that your condition is under control allowing you to enjoy life and have fun.
Your health plan gets a satisfied member because they’re helping you take care of your condition.
Your employer gets a healthier employee who is more productive and dependable.
Control and peace-of-mind in relation to the management of your condition.
Large scale deployment of real time BGM with “ Virtual Diabetes Clinic “
Connect Health Solutions are delighted to be integrated in the ground breaking delivery of a large scale deployment of its Telcare real time BGM within Ulster General Hospitals “ Virtual Diabetes Clinic ” under the guidance of Dr Harper and his team.
The team will deploy the Telcare real time BGM to the Gestational Diabetes cohort in order to significantly improve patient care, adherence to blood glucose testing and deliver a secure improvement in communication between patient and clinician.
This will result in significant cost savings as it reduces the amount of time spent by nurses and midwives on administrative tasks and allows for accurate auditing of BGM data to improve patient outcomes.
YYF & Royal Gwent Hospital have engaged in a deployment and strategic role out of the CHS UK (Telcare) real time diabetes monitoring program in gestational diabetes under the leadership of Janice Moses (DSN) with the evaluation under the guidance of Dr Julie Platt – National Clinical Lead NHS Wales
CHS would like to congratulate Toby and all the team at DPC 2017 for a fantastic event.
We were delighted to re connect with ; Dr Partha Kar ( Associate National Clinical Director for Diabetes, NHS England ) Dr Iain Cranston ( Consultant Diabetes Physician, Portsmouth NHS Trust ) Charles Fox ( Physician, R&D unit, Northampton General Hospital ). The presentations delivered were both informative and inspiring.
The presentation by Dr Michela Rossi “ Understanding and Managing Gestational Diabetes in primary and secondary care “ has given CHS great belief that delivering the Telcare BGM to the NHS is a technological solution to better patient outcomes and care.
Interesting slide by Dr Iain Cranston at DPC 2017
CHS UK attend the latest SBRI Healthcare in collaboration with AHSN event at Nottingham University.
Key notes: solution impact on the clinical care pathway, and how will the care pathway need to be changed in order to deliver system-wide benefits?
How to ensure that the technology will be acceptable to patients (and their families) and to healthcare workers? How could these groups be involved in the development of the innovation? How to ensure that the technology is affordable to the NHS both immediately and throughout the life of the product? What health economics evidence will the NHS require before the technology can be adopted?
Pregnant women with Diabetes face unacceptable standards of care. Only one in 12 women with diabetes are receiving all three key recommended pre -pregnancy health measures, according to an audit looking at the standard of care in expectant mothers.
Pregnant women with Diabetes face unacceptable standards of care.
Connect Health Solutions announce collaboration with Diabetes Complete Care Ltd ( DCCL ).
This collaborative initiative Diabetes Complete Care will enable CHS to avail of the services of DCCL's Maureen Chadwick, who has for 25 years been educating and developing diabetic nurses and care teams throughout NHS UK.
Connect Health Solutions attend Health and Care Innovation Exposition.
Founder, Richard Bray and Director Simon Dempsey attended the NHS 2017 Healthcare Exposition and were met with great interest.
CHS UK announced it had renewed its supplier agreement with Telcare Inc
Connect Health Solutions UK Limited are pleased to announce our continued agreements with Telcare Inc. We are pleased to also announce that quality assurance certification has been received from TUV, Reinland, for the use in Europe of Telcare’s blood glucose self – monitoring devices.
Aneurin Bevan University Health Board place Blood Glucose devices within the Gestational Diabetes sector.
Connect Health Solutions UK Limited are extremely pleased to announce a partnership with NHS Wales in delivering telemetry and GSM based realtime Blood Glucose devices to Gestational Diabetics at Neville Hall Hospital, YYF and The Royal Gwent hospital.
Diabetes pilot scheme with Eddie Stobart.
Connect Health Solutions are pleased to announce that they have started a diabetes pilot scheme with Eddie Stobart using real time telemetry to monitor it’s diabetic work force. Eddie Stobart are the first haulier in Europe to use such technology. Please see download section for more details
Stricter rules for self-monitoring diabetes by holders of PCV and LGV driving licences have come into force.
The change has not been publicised by the Driver and Vehicle Licensing Agency ( DVLA ) Up to now, the rules have stated that a professional driver on the sulphonylurea or glinide group of tablets must check their blood glucose levels with a finger prick test at least twice a day and at times relevant to driving.
Diabetes Research & Wellness Foundation (DRWF) a national charity established in 1998 to fund vital research into diabetes fundamentally providing support to people living with the condition.
This popular event now in it's 8th year attracts healthcare professionals across Hampshire and Wessex to exhibit across 4 different areas of communication, Health, Technology, Community and Social Media.
The aim of the day is to ensure that people living with Diabetes have access to the most contemporary information via numerous channels and support to develop a proactive self-care approach to managing their condition.
CHS were proud to exhibit and deliver a clear management program for Diabetics and to be involved with the professional care teams in both the Portsmouth and Southampton Hospitals that both provide excellent care to their Diabetics, was truly enlightening.
A really successful day for all, long may these forums and events continue
New delivery of devices and strips ready for large scale deployment at NHS Ulster Hospital.
After the successful trial in Gestational Diabetes the team in Ulster have requested new devices and strips for their continuous care of Gestational Diabetics. The news has been warmly welcomed and part of the ever evolving strategic alliance with the NHS. A blue print has now been developed which can be used as the basis for future deployment within other CCGS’s across the UK.
The collaborative partnership between patients and healthcare providers is key to maintaining an effective and efficient health care service, telemetry offers assistance in feeing up valuable time and resource to us used elsewhere, whilst still providing the level of care required to achieve clinical effectiveness and reliability.
“These are exciting times, we providing a telemetry based platform and management program to Gestational diabetics giving both the care provider and patient real time usable results, where if action is required both are in a position to do so, reducing the risk of further complications, costs, discomfort and timely interventions” stated Simon Dempsey, Director of CHS.
The Diabetes team at South Eastern HSC are keen to promote our services to “help meet the ever growing demand on diabetes and pregnancy services due to the increasing number of women being diagnosed with gestational diabetes”.
A pilot study for Gestational diabetes has now been approved under the guidance of Julia Platts, Cardiff and Vale UHB.
With the continual advancement of technology based treatments, effective information and the increasing general public and profession expectations, the NHS has to make tough decisions about how and which treatments are funded.
In Wales and the composition of numerous different Health Boards the decision to make medicines routinely available is more evidence based. With all medicine approved by NICE being readily available in Wales there are some requests received for healthcare that fall outside the routinely funded range of services and includes requests for treatment and medicines that are not routinely available within NHS Wales. These requests are referred to as Individual Patient Funding Requests (IPFR).
The challenge is for Health Boards to find a balance in providing medicine and care for the majority of the population, however, still maintaining the flexibility in providing services to accommodate individual’s needs. The ability for a Health Board to meet local need within the resource available is based on a comprehensive range of policies and strategic implementation of a schedule of services. The framework does allow and will continually consider requests for IPFR’s, however, as in the majority of cases these costs of deployment will no doubt exceed resources available.
In actual terms to have IPFR approval for a patient is a huge milestone achieved by Connect Health Solutions (CHS) as this is and will remain one of the most difficult decisions a Health Board will have to make outside of traditional policy.
CHS is currently discussing with a specialist team at Aneurin Health Board to deliver a fully functional pilot in Gestational Diabetes. The clinical effectiveness and efficiency, economic and evidence based methodology used in Ulster Hospital where they are now deploying devices and strips to Gestational Diabetics, has provided key insight into the telemetry based diabetic management systems CHS deliver.
Simon Dempsey, Director of CHS states “We are delighted to have successfully achieved funding with Aneurin Health Board for a 3-month pilot in Gestational Diabetes, we all look forward to working with the team in delivering our comprehensive and telemetry based management platform to Gestational Diabetics, assisting in maintaining healthy mums and babies with clinically effective results and satisfied users”
Connect Health Solutions are pleased to announce that we have jaoined with Eddie Stobart to run a pilot Scheme for the diabetics among the work force.
Download Professional Driver Empowered Diabetes management programme
Connect Health Solutions are pleased to be working with Dr Roy Harper and his team from the Ulster Hospital, Belfast..
We are very pleased to announce that Dr Harper has completed a pilot study within “ Gestational Diabetes “ of which the results will offer ground breaking benefits for the patient and care giver.
Please download our white paper here
Some answers to Frequently Asked Questions about our product and service
Immediately after each test with the cellular-enabled meter, patients receive personalized, contextual messaging right on the meter’s screen, which helps influence behaviour at the most teachable moment. In response to specific levels of blood sugar readings, triggered messages can be automatically generated. There’s also a custom messaging tool that lets healthcare professionals send individual messages to the meter, your mobile, or email address. For people with diabetes, there are multiple libraries for Type 2, Type 1, and gestational patients, all designed to provide personalized engagement.
You and your healthcare provider should work together to determine your personal goals. Once this consultation occurs, you can adjust your target ranges within the clinical profile of your mytelcare.com account. If your healthcare provider also participates in the Telcare solution, and has access to your personal Telcare data, he/she has the option to set up a target range for you as well; this personalized target range will appear on your meter when you take a reading.
Each blood glucose reading is automatically sent to mytelcare.com. The cellular service is provided to you free of charge and there are no contracts to sign. The Telcare Blood Glucose Meter’s embedded cellular technology enables data to be submitted to mytelcare.com anywhere cellular coverage is available. The strength of the cellular signal is indicated on the screen of your blood glucose meter. It’s a fully roaming device and uses the strongest signal in the area you conduct your text.
The Telcare Blood Glucose Meter will allow you to check your blood glucose levels regardless of cellular connection. As long as the battery is charged, you can use it. In most instances, cellular coverage will be sufficient to send the data to mytelcare.com. However, if the Telcare Blood Glucose Meter is unable to send the data, it will be stored in internal memory and the meter will attempt to send it to mytelcare.com again the next time your meter is used. The Telcare Blood Glucose Meter can store up to 300 readings.
Even if you lose or damage your Telcare blood glucose meter, all data previously sent to mytelcare.com will be available and secure.
+44 (0)1625 509 125
Lyme Green Business Park Winterton Way